Contract facts
NONECDER ORACLE DBA SUPPORT is a federal NONE award for Fda Office Of Acq Grant Svcs held by Tuvli LLC. Estimated value $135.3M ($135.3M obligated). Current period of performance ends Aug 24, 2028 (potential Sep 30, 2028). Last award drew 1 bidder. Place of performance: ROCKVILLE, MD. Related solicitation 75F40123Q00110.
Recompete timing
PublicCurrent PoP ends Aug 24, 2028 (735 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Feb 24, 2027.
Incumbent footprint
Public recordTuvli LLC — $201.7M obligated across 187 awards (firm-wide, all agencies) · lead buyer Department of State (DOS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40123F19002?
75F40123F19002 (CDER ORACLE DBA support) is a Fda Office Of Acq Grant Svcs award with an estimated value of $135.3M, currently held by Tuvli LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40123F19002?
Fda Office Of Acq Grant Svcs awarded 75F40123F19002 to Tuvli LLC.
Who is the incumbent on 75F40123F19002?
Tuvli LLC is the incumbent with $201.7M across 187 related awards in SCOUT’s public footprint. The current period of performance ends Aug 24, 2028.
When does Tuvli LLC’s 75F40123F19002 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 24, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
